The Biostatistics Facility is a shared institutional resource for biostatistical collaboration and related methodological research. It is recognized as an important aspect of the research infrastructure at the Fox Chase Cancer Center (FCCC). The Facility serves as a focal point from which the Center's investigators may draw statistical expertise for planning, management, and analysis of their studies. This effort spans all three FCCC Divisions and 10 Research Programs. Between January 2000 and June 2004, Facility biostatisticians were involved in the publication of 139 papers and in the design of 261 in-house clinical protocols. During the current funding cycle, this Core has actively served the needs of 69 investigators with peer-reviewed funding on statistical issues concerning their research projects. The Facility was rated """"""""Outstanding"""""""" at the last CCSG review. In 2003 the Facility logged 5,464 consulting hours with 91% in support of investigators with peer-reviewed funding.
The specific aims of the Biostatistics Facility are: (1) Coordinate and manage statistical activities in the Cancer Center to ensure that every investigator has ready access to statistical consultation and support. (2) Provide statistical expertise in the design of experiments and studies, including research proposal development, sample size determination, randomization procedures, and plans for interim reviews and final analysis. (3) Provide statistical analysis for Cancer Center projects using appropriate statistical and computing methodologies, assist in the interpretation and presentation of results. (4) Provide statistical components for manuscripts. (5) Review, in conjunction with the Scientific Review Committee, the integrity and statistical soundness of all studies involving human subjects. (6) Interact and collaborate with the Population Studies Facility to ensure the retrieval of relevant and valid data. (7) Interact and collaborate with the Protocol Office in the development of protocols and the monitoring and reporting of clinical data. (8) Maintain a library of up-to-date software for statistical analysis. (9) When necessary, develop specialized methods that are clearly and closely related to the support of specific Cancer Center projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-47
Application #
7881768
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
47
Fiscal Year
2009
Total Cost
$586,959
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Sementino, Eleonora; Menges, Craig W; Kadariya, Yuwaraj et al. (2018) Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. J Cell Physiol 233:8952-8961
Gupta, Sapna; Kelow, Simon; Wang, Liqun et al. (2018) Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine ?-synthase (CBS) reveal effects on CBS activity but not stability. J Biol Chem 293:13921-13931
Peng, Hongzhuang; Prokop, Jeremy; Karar, Jayashree et al. (2018) Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res 78:1200-1213
Araiza-Olivera, Daniela; Chernoff, Jonathan (2018) Hras helps hippo heterodimerize to evade tumor suppression. Small GTPases 9:327-331
Shaikh, Talha; Handorf, Elizabeth A; Meyer, Joshua E et al. (2018) Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol 4:e173580
Reese, Jennifer Barsky; Smith, Katherine Clegg; Handorf, Elizabeth et al. (2018) A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol :1-22
Auerbach, M V; Heckman, C J; Darlow, S (2018) To protect or not to protect: examining reasons for sun protection among young women at risk for skin cancer. J Behav Med 41:528-536
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886

Showing the most recent 10 out of 1280 publications